Hyperprogression: How Immunotherapy Frequently Leads to Worsening Cancer

Executive Summary

  • Immunotherapy often worsens cancer and further weakens the patient.
  • In this article, we discuss what the articles that cover immunotherapy on sites that promote the topic do not cover.


A significant side effect of immunotherapy is called hyperprogression, or HPD. Hyperprogression is where the immunotherapy drug worsens the impact of cancer that immunotherapy is trying to improve.

Wait One Second...

Why is The Article Not Viewable?

You are seeing this text instead of the article because of two potential reasons.

Reason #1: You are a Subscriber but Not Signed In

You can sign in by simply sending yourself a link to the email you signed in with by going here.

It's as easy as 1,2,3.  

You can read any article on the site as soon as you sign in.

Reason #2: You Are Not Yet Subscribed to the Site

This is a subscription site. That is how we pay for the research we do. We have to charge subscribers to access articles because, unlike WebMD, Healthline, or the Mayo Clinic, we don't allow pharmaceutical companies to write or edit our articles. 

You can access this and many other articles by becoming a subscriber.

How Do You Subscribe?

See the following article, which explains what you get with a subscription Subscribe to the Site.

You can be reading this article and many others like it in just a few minutes from now.